Have Patent, Will Travel: Brand Firms Can File Infringement Suits Anywhere

Federal Circuit denies Mylan's bid to dismiss litigation in Delaware; PhRMA, BIO and Teva argued that brand manufacturers should be allowed to sue multiple generic manufacturers in a single forum.